AUS
NZ
UK
CA
USA
IND
Highlights
ASX 200 hits new high above 8700
BHP delivers record-breaking operational review
Mesoblast rallies with renewed momentum
Australia’s equity market surged into record territory as the ASX 200 soared past the 8700 mark during lunchtime trading. All 11 sectors posted gains, reflecting a broad-based rally across the ASX top 300, triggered by strong cues from Wall Street and a wave of optimism flowing into Asia. This upward momentum was notably powered by exceptional performances from major companies such as BHP (BHP) and Mesoblast (MSB), both of which made significant headlines.
Wall Street Ripple Lifts ASX Confidence
The strong push from Wall Street was underpinned by robust economic indicators, including an upbeat retail performance and a declining trend in jobless claims. This renewed economic sentiment helped set the tone for a bullish session across global markets. Major tech companies in the US contributed to the global momentum, with bullish energy spilling into the Asia-Pacific region. Taiwan Semiconductor (TSMC) recorded gains in Taiwan, influenced by rising confidence in the AI segment.
This market-wide optimism lifted the Australian Securities Exchange to new heights, with across sectors buoyed by solid fundamentals and global cues. Notably, stocks across mining, healthcare, and technology sectors were among the leaders in performance.
BHP’s Operational Review Delivers Historic Highs
The spotlight of the trading session was clearly on BHP (ASX:BHP), which announced a standout annual operational review. With its core operations in Western Australia, the mining giant reported record output levels across multiple commodities.
Iron ore production reached new milestones, with key projects like South Flank operating above its initial capacity projections. Despite challenges posed by adverse weather and geological issues in its coal segment, BHP managed to increase overall coal output.
However, it was copper that truly stood out. BHP posted a record copper haul across its global operations, further cementing its role in supplying a metal crucial to clean energy transformation. Escondida in Chile delivered its highest production in more than a decade, and operations at Spence and Copper SA added to the stellar numbers. While the numbers impressed, BHP did face cost and timing challenges at its upcoming Jansen potash project in Canada. As part of the ASX top 300, BHP’s performance has become a key metric in assessing the broader market sentiment.
Mesoblast Gains Momentum
Biotech firm Mesoblast (ASX:MSB) also captured attention with its share price moving strongly during the session. The renewed momentum around the company a reinvigorated outlook as it progresses with its cell therapy developments. While the broader healthcare sector followed the market rally, Mesoblast stood out as one of the top movers by mid-session.
Though the details around the catalyst for the surge remain closely watched, Mesoblast’s inclusion in conversations around regenerative medicine and innovation continues to draw attention. The broader gains across the healthcare sector provided additional tailwinds.
ASX 200 Marks New Era
Crossing the 8700 threshold for the first time marks a psychological and technical milestone for the Australian share market. The gains weren’t isolated to a few sectors; instead, every segment contributed, creating a unified market rise.
The ASX 200’s historic run also reinforces the strength of Australian companies in responding to global demand trends, commodity shifts, and technological evolution. As macroeconomic confidence builds and sector fundamentals strong, the stage appears set for continued attention on companies delivering operational excellence like BHP and breakthrough innovation like Mesoblast.
With both resource strength and biotech resilience in play, the ASX continues to reflect a dynamic and evolving economic narrative.
